Cost-effectiveness analysis of durvalumab versus atezolizumab as a first-line treatment for extensive-stage small cell lung cancer
CHEN Yeli, LONG Yunchun, CHEN Fang, CHEN Yu
Chinese Journal of Hospital Pharmacy . 2024, (7): 815 -821 .  DOI: 10.13286/j.1001-5213.2024.07.11

Information
Governed by: China Association for Science and Technology
Sponsored by: Chinese Pharmaceutical Association
Published by: Editorial Office of Chinese Journal of Hospital Pharmacy
ISSN 1001-5213
CN 42-1204/R
Contact
Website Copyright © Chinese Journal of Hospital Pharmacy, All Rights Reserved.
Tel: 027-82836596
E-mail：pharmacy@vip.163.com
Wechat